Marker Therapeutics Inc (MRKR)

[$$$eeker]

$TPIV
TapImmune Inc.

24,640,000 Shares of Common Stock

This prospectus supplement no. 1 supplements the prospectus dated August 7, 2015, which forms a part of our registration statement Form S-1 (Registration Statement No. 333-205757) relating to the resale of up to 24,640,000 shares of our common stock by the selling stockholders named in the “Selling Stockholders” section of the prospectus. We will not receive any proceeds from the sale of our shares by the selling stockholders.

This prospectus supplement is being filed to update and supplement the information included or incorporated by reference in the prospectus with the information contained in our Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on November 16, 2015 (the “Report”). Accordingly, we have attached the Report to this prospectus supplement.

The attached information amends and supplements certain information contained in the prospectus. This prospectus supplement is not complete without, and should not be delivered or utilized, except in conjunction with the prospectus, including any supplements and amendments thereto. You should read this prospectus supplement in conjunction with the prospectus, including any supplements and amendments thereto.

Our common stock is traded on the OTCQB marketplace under the symbol “TPIV.” On November 16, 2015, the last reported closing price of our common stock was $0.64 per share.

http://bit.ly/218ABUs